Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 313
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants
Phase IV
COLOGEN
NCT00138060
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Phase IV
GERCOR-TAUROX
SANOFI-GERCOR-TAUROX, EU-20573, NCT00274885
Preoperative Assessment for Synchronous Carcinoma or Polyps With MR Colonography
Phase IV
KA05030-MA
KA05030, NCT00300547
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
Phase IV
2005-401
NCT00327093
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Phase IV
ML20592
NCT00502671
Concentration of Ertapenem in Colorectal Tissue
Phase IV
01-07
NCT00535652
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
Phase IV
CHUL-BIO-COLON
RECF0356, INCA-RECF0356, NCT00559676
PSD Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery
Phase IV
CP1011, Rev C
NCT00559013
OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
Phase IV
ML21380
NCT00577031
Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (= 75 Years)
Phase IV
I07028
N° EudraCT : 2008-001195-7, NCT00812864
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute